Veru Investor Relations Material
Latest events
Q2 2025
Veru
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Veru Inc
Access all reports
Segment Data
Access more data
Net revenue by
Category
U.S. prescription channel
Global public health sector
Other
Expenses by
Financials
Veru, Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. The company's lead product is currently in Phase III clinical trials, and it has also initiated Phase II trials with additional compounds targeting other therapeutic areas. Veru's clinical development pipeline includes two compounds formulated with cationic polymers, one of which was designed to improve the delivery of a select class of cancer therapeutics. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
VERU
Country
🇺🇸 United States